GL1X · GenesisL1 explorer

MolNFT v1 · #128628 · protein

Potent inhibitors of NUDT5 silence hormone signaling in breast cancer

5NWH · ADP-sugar pyrophosphatase: “Potent inhibitors of NUDT5 silence hormone signaling in breast cancer”. X-ray diffraction, 1 ligand (9CH), 4 pockets (best druggability 0.73). MolNFT v1 #128628 on GenesisL1: 3D structure, binding sites…

PDB
5NWH
Type
protein
Length
388 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ADP-sugar pyrophosphatase
EC
3.6.1.13, 3.6.1.58, 2.7.7.96
UniProt
Q9UKK9
Ligands
9CH
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 20% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AADP-sugar pyrophosphatase (EC 3.6.1.13, 3.6.1.58, 2.7.7.96)protein19320% helix, 42% strandQ9UKK9
BADP-sugar pyrophosphatase (EC 3.6.1.13, 3.6.1.58, 2.7.7.96)protein19520% helix, 43% strandQ9UKK9

Ligands and binding sites

  • 9CH · 7-[[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-1,3-dimethyl-8-piperazin-1-yl-purine-2,6-dione · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13850.730.84409CH
23860.730.84499CH
3960.380.7627empty
4500.230.7217empty

Interfaces

1 interface between chains.

  • A–B · 3190 Ų buried · 32 hydrogen bonds · protein-protein

Compared structures

  • 5NWH · Potent inhibitors of NUDT5 silence hormone signaling in breast cancer · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.